Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Predicting Protein-Protein Interfaces that Bind Intrinsically Disordered Protein Regions.

Wong ETC, Gsponer J.

J Mol Biol. 2019 Aug 9;431(17):3157-3178. doi: 10.1016/j.jmb.2019.06.010. Epub 2019 Jun 15.

PMID:
31207240
2.

IgG4-Related Kidney Disease: A Curious Case of Interstitial Nephritis with Hypocomplementemia.

Wong ETY, Lahiri M, Teh M, Leo CCH.

Case Rep Nephrol Dial. 2019 May 16;9(2):49-54. doi: 10.1159/000500296. eCollection 2019 May-Aug.

3.

Quantitative ultrasound of muscle can detect corticosteroid effects.

Martucci MG, McIlduff CE, Shin C, Gutierrez HV, Nam JY, Greenstein P, Phillips K, Uhlmann EJ, Wong ET, Rutkove SB.

Clin Neurophysiol. 2019 Aug;130(8):1460-1464. doi: 10.1016/j.clinph.2019.04.709. Epub 2019 May 10.

PMID:
31122815
4.

The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma.

Riley MM, San P, Lok E, Swanson KD, Wong ET.

J Vis Exp. 2019 Apr 16;(146). doi: 10.3791/58937.

PMID:
31058901
5.

Nucleolin Is a Functional Binding Protein for Salinomycin in Neuroblastoma Stem Cells.

Wang F, Zhou S, Qi D, Xiang SH, Wong ET, Wang X, Fonkem E, Hsieh TC, Yang J, Kirmani B, Shabb JB, Wu JM, Wu M, Huang JH, Yu WH, Wu E.

J Am Chem Soc. 2019 Feb 27;141(8):3613-3622. doi: 10.1021/jacs.8b12872. Epub 2019 Feb 13.

PMID:
30689374
6.

Dexamethasone-Friend or Foe for Patients With Glioblastoma?

Wong ET, Swanson KD.

JAMA Neurol. 2019 Mar 1;76(3):247-248. doi: 10.1001/jamaneurol.2018.4530. No abstract available.

PMID:
30667471
7.

18 F-FDG PET/CT for locoregional surveillance following definitive treatment of head and neck cancer: A meta-analysis of reported studies.

Wong ET, Dmytriw AA, Yu E, Waldron J, Lu L, Fazelzad R, de Almeida JR, Veit-Haibach P, O'Sullivan B, Xu W, Huang SH.

Head Neck. 2019 Feb;41(2):551-561. doi: 10.1002/hed.25513. Epub 2018 Nov 20. Review.

PMID:
30456825
8.

Identification of a panel of genes as a prognostic biomarker for glioblastoma.

Wang F, Zheng Z, Guan J, Qi D, Zhou S, Shen X, Wang F, Wenkert D, Kirmani B, Solouki T, Fonkem E, Wong ET, Huang JH, Wu E.

EBioMedicine. 2018 Nov;37:68-77. doi: 10.1016/j.ebiom.2018.10.024. Epub 2018 Oct 16.

9.

Tubulin's response to external electric fields by molecular dynamics simulations.

Timmons JJ, Preto J, Tuszynski JA, Wong ET.

PLoS One. 2018 Sep 19;13(9):e0202141. doi: 10.1371/journal.pone.0202141. eCollection 2018.

10.

Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma.

Lukas RV, Rodon J, Becker K, Wong ET, Shih K, Touat M, Fassò M, Osborne S, Molinero L, O'Hear C, Grossman W, Baehring J.

J Neurooncol. 2018 Nov;140(2):317-328. doi: 10.1007/s11060-018-2955-9. Epub 2018 Aug 2.

PMID:
30073642
11.

The ESCRT-III Protein CHMP1A Mediates Secretion of Sonic Hedgehog on a Distinctive Subtype of Extracellular Vesicles.

Coulter ME, Dorobantu CM, Lodewijk GA, Delalande F, Cianferani S, Ganesh VS, Smith RS, Lim ET, Xu CS, Pang S, Wong ET, Lidov HGW, Calicchio ML, Yang E, Gonzalez DM, Schlaeger TM, Mochida GH, Hess H, Lee WA, Lehtinen MK, Kirchhausen T, Haussler D, Jacobs FMJ, Gaudin R, Walsh CA.

Cell Rep. 2018 Jul 24;24(4):973-986.e8. doi: 10.1016/j.celrep.2018.06.100.

12.

Alternating Electric Fields Therapy for Malignant Gliomas: From Bench Observation to Clinical Reality.

Wong ET, Lok E, Swanson KD.

Prog Neurol Surg. 2018;32:180-195. doi: 10.1159/000469690. Epub 2018 Jul 10. Review.

PMID:
29990984
13.

Everolimus shortens survival of newly diagnosed glioblastoma patients.

Wong ET, Swanson KD.

J Neurooncol. 2018 Oct;140(1):179-180. doi: 10.1007/s11060-018-2937-y. Epub 2018 Jun 28. No abstract available.

PMID:
29956084
14.

Literature Review of Spinal Cord Glioblastoma.

Timmons JJ, Zhang K, Fong J, Lok E, Swanson KD, Gautam S, Wong ET.

Am J Clin Oncol. 2018 Dec;41(12):1281-1287. doi: 10.1097/COC.0000000000000434. Review.

PMID:
29528867
15.

End-to-end workflow for finite element analysis of tumor treating fields in glioblastomas.

Timmons JJ, Lok E, San P, Bui K, Wong ET.

Phys Med Biol. 2017 Oct 12;62(21):8264-8282. doi: 10.1088/1361-6560/aa87f3.

PMID:
29023236
16.

Skin toxicities associated with tumor treating fields: case based review.

Lukas RV, Ratermann KL, Wong ET, Villano JL.

J Neurooncol. 2017 Dec;135(3):593-599. doi: 10.1007/s11060-017-2612-8. Epub 2017 Aug 28.

PMID:
28849343
17.

Analysis of physical characteristics of Tumor Treating Fields for human glioblastoma.

Lok E, San P, Hua V, Phung M, Wong ET.

Cancer Med. 2017 Jun;6(6):1286-1300. doi: 10.1002/cam4.1095. Epub 2017 May 23.

18.

Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas.

Wong ET, Timmons J, Callahan A, O'Loughlin L, Giarusso B, Alsop DC.

BMC Cancer. 2016 Nov 22;16(1):914.

19.

Evaluation of the Tobacco Heating System 2.2 (THS2.2). Part 5: microRNA expression from a 90-day rat inhalation study indicates that exposure to THS2.2 aerosol causes reduced effects on lung tissue compared with cigarette smoke.

Sewer A, Kogel U, Talikka M, Wong ET, Martin F, Xiang Y, Guedj E, Ivanov NV, Hoeng J, Peitsch MC.

Regul Toxicol Pharmacol. 2016 Nov 30;81 Suppl 2:S82-S92. doi: 10.1016/j.yrtph.2016.11.018. Epub 2016 Nov 17.

20.

Evaluation of the Tobacco Heating System 2.2. Part 4: 90-day OECD 413 rat inhalation study with systems toxicology endpoints demonstrates reduced exposure effects compared with cigarette smoke.

Wong ET, Kogel U, Veljkovic E, Martin F, Xiang Y, Boue S, Vuillaume G, Leroy P, Guedj E, Rodrigo G, Ivanov NV, Hoeng J, Peitsch MC, Vanscheeuwijck P.

Regul Toxicol Pharmacol. 2016 Nov 30;81 Suppl 2:S59-S81. doi: 10.1016/j.yrtph.2016.10.015. Epub 2016 Oct 26.

21.

Using Anatomic Magnetic Resonance Image Information to Enhance Visualization and Interpretation of Functional Images: A Comparison of Methods Applied to Clinical Arterial Spin Labeling Images.

Zhao L, Dai W, Soman S, Hackney DB, Wong ET, Robson PM, Alsop DC.

IEEE Trans Med Imaging. 2017 Feb;36(2):487-496. doi: 10.1109/TMI.2016.2615567. Epub 2016 Oct 6.

22.

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs.

Timmons JJ, Cohessy S, Wong ET.

J Vis Exp. 2016 May 24;(111). doi: 10.3791/54039.

23.

A randomized, placebo-controlled pilot trial of armodafinil for fatigue in patients with gliomas undergoing radiotherapy.

Lee EQ, Muzikansky A, Drappatz J, Kesari S, Wong ET, Fadul CE, Reardon DA, Norden AD, Nayak L, Rinne ML, Alexander BM, Arvold ND, Doherty L, Stefanik J, LaFrankie D, Ruland SF, Pulverenti J, Smith KH, Gaffey SC, Hammond S, Wen PY.

Neuro Oncol. 2016 Jun;18(6):849-54. doi: 10.1093/neuonc/now007. Epub 2016 Feb 21.

24.

Technological Advances in the Treatment of Cancer: Combining Modalities to Optimize Outcomes.

Wong ET, Toms SA, Ahluwalia MS.

Clin Adv Hematol Oncol. 2015 Nov;13(11 Suppl 11):1-18.

PMID:
26862770
25.

Neurological presentations of intravascular lymphoma (IVL): meta-analysis of 654 patients.

Fonkem E, Dayawansa S, Stroberg E, Lok E, Bricker PC, Kirmani B, Wong ET, Huang JH.

BMC Neurol. 2016 Jan 16;16:9. doi: 10.1186/s12883-015-0509-8.

26.

An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma.

Swanson KD, Lok E, Wong ET.

Curr Neurol Neurosci Rep. 2016 Jan;16(1):8. doi: 10.1007/s11910-015-0606-5. Review.

27.

Stereotactic Radiosurgery for Renal Cancer Brain Metastasis: Prognostic Factors and the Role of Whole-Brain Radiation and Surgical Resection.

Ippen FM, Mahadevan A, Wong ET, Uhlmann EJ, Sengupta S, Kasper EM.

J Oncol. 2015;2015:636918. doi: 10.1155/2015/636918. Epub 2015 Nov 19.

28.

Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma.

Wong ET, Lok E, Gautam S, Swanson KD.

Br J Cancer. 2015 Dec 1;113(11):1642. doi: 10.1038/bjc.2015.404. No abstract available.

29.

Dosimetric analysis of the alopecia preventing effect of hippocampus sparing whole brain radiation therapy.

Mahadevan A, Sampson C, LaRosa S, Floyd SR, Wong ET, Uhlmann EJ, Sengupta S, Kasper EM.

Radiat Oncol. 2015 Nov 26;10:245. doi: 10.1186/s13014-015-0555-9.

30.

Computational Identification of MoRFs in Protein Sequences Using Hierarchical Application of Bayes Rule.

Malhis N, Wong ET, Nassar R, Gsponer J.

PLoS One. 2015 Oct 30;10(10):e0141603. doi: 10.1371/journal.pone.0141603. eCollection 2015.

31.

Tumor treating fields therapy device for glioblastoma: physics and clinical practice considerations.

Lok E, Swanson KD, Wong ET.

Expert Rev Med Devices. 2015;12(6):717-26. doi: 10.1586/17434440.2015.1086641. Epub 2015 Oct 29. Review.

PMID:
26513694
32.

Diagnostic Accuracy of PET, SPECT, and Arterial Spin-Labeling in Differentiating Tumor Recurrence from Necrosis in Cerebral Metastasis after Stereotactic Radiosurgery.

Lai G, Mahadevan A, Hackney D, Warnke PC, Nigim F, Kasper E, Wong ET, Carter BS, Chen CC.

AJNR Am J Neuroradiol. 2015 Dec;36(12):2250-5. doi: 10.3174/ajnr.A4475. Epub 2015 Oct 1.

33.

Stereotactic radiosurgery for brain metastases from malignant melanoma.

Christ SM, Mahadevan A, Floyd SR, Lam FC, Chen CC, Wong ET, Kasper EM.

Surg Neurol Int. 2015 Aug 20;6(Suppl 12):S355-65. doi: 10.4103/2152-7806.163315. eCollection 2015.

34.

Response to: Comment on 'Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma'.

Wong ET, Swanson KD.

Br J Cancer. 2015 Dec 1;113(11):1633-4. doi: 10.1038/bjc.2015.320. Epub 2015 Sep 8. No abstract available.

35.

Computed modeling of alternating electric fields therapy for recurrent glioblastoma.

Lok E, Hua V, Wong ET.

Cancer Med. 2015 Nov;4(11):1697-9. doi: 10.1002/cam4.519. Epub 2015 Aug 26.

36.

An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas.

Wong ET, Lok E, Swanson KD.

Curr Treat Options Oncol. 2015 Aug;16(8):40. doi: 10.1007/s11864-015-0353-5. Review.

37.

Dexamethasone exerts profound immunologic interference on treatment efficacy for recurrent glioblastoma.

Wong ET, Lok E, Gautam S, Swanson KD.

Br J Cancer. 2015 Jul 14;113(2):232-41. doi: 10.1038/bjc.2015.238. Epub 2015 Jun 30. Erratum in: Br J Cancer. 2015 Dec 1;113(11):1642.

38.

Tumor treating fields perturb the localization of septins and cause aberrant mitotic exit.

Gera N, Yang A, Holtzman TS, Lee SX, Wong ET, Swanson KD.

PLoS One. 2015 May 26;10(5):e0125269. doi: 10.1371/journal.pone.0125269. eCollection 2015.

39.

A Multicenter, Phase II, Randomized, Noncomparative Clinical Trial of Radiation and Temozolomide with or without Vandetanib in Newly Diagnosed Glioblastoma Patients.

Lee EQ, Kaley TJ, Duda DG, Schiff D, Lassman AB, Wong ET, Mikkelsen T, Purow BW, Muzikansky A, Ancukiewicz M, Huse JT, Ramkissoon S, Drappatz J, Norden AD, Beroukhim R, Weiss SE, Alexander BM, McCluskey CS, Gerard M, Smith KH, Jain RK, Batchelor TT, Ligon KL, Wen PY.

Clin Cancer Res. 2015 Aug 15;21(16):3610-8. doi: 10.1158/1078-0432.CCR-14-3220. Epub 2015 Apr 24.

40.

Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers.

Rangachari D, Yamaguchi N, VanderLaan PA, Folch E, Mahadevan A, Floyd SR, Uhlmann EJ, Wong ET, Dahlberg SE, Huberman MS, Costa DB.

Lung Cancer. 2015 Apr;88(1):108-11. doi: 10.1016/j.lungcan.2015.01.020. Epub 2015 Feb 4.

41.
42.

A microRNA-1280/JAG2 network comprises a novel biological target in high-risk medulloblastoma.

Wang F, Remke M, Bhat K, Wong ET, Zhou S, Ramaswamy V, Dubuc A, Fonkem E, Salem S, Zhang H, Hsieh TC, O'Rourke ST, Wu L, Li DW, Hawkins C, Kohane IS, Wu JM, Wu M, Taylor MD, Wu E.

Oncotarget. 2015 Feb 20;6(5):2709-24.

43.

The Enhanced Workflow and Efficiency of the Wireless Local Area Network (WLAN)-Based Direct Digital Radiography (DDR) Portable Radiography.

Ngan TL, Wong ET, Ng KL, Jeor PK, Lo GG.

J Digit Imaging. 2015 Jun;28(3):302-8. doi: 10.1007/s10278-014-9764-2.

44.

Phase II study of monthly pasireotide LAR (SOM230C) for recurrent or progressive meningioma.

Norden AD, Ligon KL, Hammond SN, Muzikansky A, Reardon DA, Kaley TJ, Batchelor TT, Plotkin SR, Raizer JJ, Wong ET, Drappatz J, Lesser GJ, Haidar S, Beroukhim R, Lee EQ, Doherty L, Lafrankie D, Gaffey SC, Gerard M, Smith KH, McCluskey C, Phuphanich S, Wen PY.

Neurology. 2015 Jan 20;84(3):280-6. doi: 10.1212/WNL.0000000000001153. Epub 2014 Dec 19.

45.

A versatile platform to analyze low-affinity and transient protein-protein interactions in living cells in real time.

Li YC, Rodewald LW, Hoppmann C, Wong ET, Lebreton S, Safar P, Patek M, Wang L, Wertman KF, Wahl GM.

Cell Rep. 2014 Dec 11;9(5):1946-1958. doi: 10.1016/j.celrep.2014.10.058. Epub 2014 Nov 20.

46.

A feature analysis of lower solubility proteins in three eukaryotic systems.

Albu RF, Chan GT, Zhu M, Wong ET, Taghizadeh F, Hu X, Mehran AE, Johnson JD, Gsponer J, Mayor T.

J Proteomics. 2015 Apr 6;118:21-38. doi: 10.1016/j.jprot.2014.10.011. Epub 2014 Oct 25.

PMID:
25451012
47.

Post Hoc analyses of intention-to-treat population in phase III comparison of NovoTTF-100A™ system versus best physician's choice chemotherapy.

Kanner AA, Wong ET, Villano JL, Ram Z; EF-11 Investigators.

Semin Oncol. 2014 Oct;41 Suppl 6:S25-34. doi: 10.1053/j.seminoncol.2014.09.008. Epub 2014 Sep 16. Erratum in: Semin Oncol. 2015 Jun;42(3):e56-66.

48.

Response patterns of recurrent glioblastomas treated with tumor-treating fields.

Vymazal J, Wong ET.

Semin Oncol. 2014 Oct;41 Suppl 6:S14-24. doi: 10.1053/j.seminoncol.2014.09.009. Epub 2014 Sep 16. Erratum in: Semin Oncol. 2015 Jun;42(3):e44-55.

49.

Psychosocial perception of adults with onychomycosis: a blinded, controlled comparison of 1,017 adult Hong Kong residents with or without onychomycosis.

Chan HH, Wong ET, Yeung CK.

Biopsychosoc Med. 2014 Jul 15;8:15. doi: 10.1186/1751-0759-8-15. eCollection 2014.

50.

The natural history of intravascular lymphomatosis.

Fonkem E, Lok E, Robison D, Gautam S, Wong ET.

Cancer Med. 2014 Aug;3(4):1010-24. doi: 10.1002/cam4.269. Epub 2014 Jun 14.

Supplemental Content

Support Center